Premium
HIV and reproductive care—a review of current practice
Author(s) -
GillingSmith C,
Nicopoullos JDM,
Semprini AE,
Frodsham LCG
Publication year - 2006
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.2006.00960.x
Subject(s) - fertility , life expectancy , human immunodeficiency virus (hiv) , pregnancy , medicine , transmission (telecommunications) , viral load , population , demography , sexual intercourse , antiretroviral treatment , obstetrics , environmental health , antiretroviral therapy , gynecology , family medicine , biology , sociology , electrical engineering , genetics , engineering
In developed countries, antiretroviral treatment has increased life quality and expectancy of HIV‐infected individuals and led to a drop in mother‐to‐child transmission (MCT) risk to below 1%. Fertility has been shown to be reduced in both men and women with HIV. As a result of these factors, the demand for reproductive care in this population is rising. In discordant couples where the man is positive, sperm washing significantly reduces viral transmission risk to the uninfected female partner over unprotected intercourse. Positive women do not necessarily need specialised fertility treatment but should be monitored closely during pregnancy to minimise MCT risk.